Clinical Trial: A Trial Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes

U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT06871761) titled 'A Trial Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes' on Feb. 26.

Brief Summary: To compare the efficacy and safety of HR17031 injection and insulin glargine, including the changes of efficacy indicators such as HbA1c, fasting blood glucose, body weight and safety indicators such as adverse events and hypoglycemic events.

Study Start Date: May 08, 2024

Study Type: INTERVENTIONAL

Condition: Adult Patients With Type 2 Diabetes

Intervention: DRUG: HR17031 injection

HR17031 injection

DRUG: insulin glargine

insulin glargine

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: Jiangsu HengRui Medicine...